Skip to content
Case report

Beyond the liver: Hepatitis E virus-associated Guillain-Barré syndrome with respiratory failure in an adolescent, a case report.

Oct 2026 · Journal of the National Medical Association · Vol 118 6, pp. 101116 · 0 citations · 19 references
Medicine

TL;DR

HEV is an under-recognized trigger for severe GBS in adolescents, and should be considered in cases of acute flaccid paralysis presenting with concurrent hepatic dysfunction, where delayed diagnoses may result in poor clinical outcomes.

Abstract

Background

Hepatitis E virus (HEV) remains endemic worldwide, especially in resource-constrained settings. Although HEV-associated Guillain-Barré syndrome (GBS) is well documented in adults, severe presentations in adolescents are scarcely reported. CASE PRESENTATION A previously healthy 12-year-old female presented with progressive ascending weakness and rapidly progressive respiratory failure requiring mechanical ventilation. Acute hepatitis E infection was diagnosed based on positive anti-HEV IgM antibodies, confirmed by detection of HEV RNA on real-time reverse-transcriptase PCR (RT-PCR). Cerebrospinal fluid protein and cell count were normal, consistent with early-stage GBS. A diagnosis of HEV-associated GBS was made. Despite intravenous immunoglobulin therapy and intensive supportive care, the clinical course remained severe, and the patient ultimately died after withdrawal of care due to financial constraints.

Conclusion

HEV is an under-recognized trigger for severe GBS in adolescents, and should be considered in cases of acute flaccid paralysis presenting with concurrent hepatic dysfunction. Early recognition, therefore, remains paramount, particularly in resource-limited, endemic regions, where delayed diagnoses may result in poor clinical outcomes.

View source

Similar papers

Review Open access Jan 2026

Clinically Probable Guillain-Barré Syndrome and Herpesvirus-Associated Syndromes in Advanced Untreated HIV: A Retrospective Case Cluster from India.

BackgroundGuillain-Barré syndrome (GBS) can be difficult to recognise in advanced untreated HIV, particularly where cerebrospinal fluid analysis and electrophysiology are unavailable.MethodsWe retrospectively reviewed adults with advanced HIV who were not receiving antiretroviral therapy and presented with acute symmet...

Muralidhar Yanamadala · 0 citations
Case report Oct 2026

Acute autoimmune hepatitis diagnosed concurrently with human immunodeficiency virus.

De novo AIH presenting concurrently with advanced HIV and profound immunosuppression is exceptionally rare, with few reported cases in the literature, and diligent investigation can uncover rare but treatable causes of liver dysfunction.

George Lennox, A. Arnaout, Lisa Hamzah et al. · 0 citations
Open access Sep 2026

Acute Viral Hepatitis A in Children: Clinical and Biochemical Profile-Tertiary Care Hospital Study

Objective: Hepatitis A is an acute infection of liver caused by the hepatitis A virus (HAV), a non-enveloped RNA virus of the Picornaviridae family. It can present with a wide spectrum of severity, from asymptomatic seroconversion to fulminant hepatic failure, due to its high transmissibility and the persistent challen...

Lalit Seju, Lipika Maru, Prerna Vaishnav · 0 citations
Open access Sep 2026

Guillain-Barré Syndrome Following the Administration of Tarlatamab in Extensive-stage Small Cell Lung Cancer: A Case Report with Pathological Confirmation.

We report a rare case of Guillain-Barré syndrome (GBS) following treatment with tarlatamab, a bispecific T-cell engager targeting DLL3 and CD3, in a patient with extensive-stage small cell lung cancer (SCLC). After the initial dose, the patient developed grade 2 cytokine release syndrome, followed by progressive weakne...

Yoshihisa Tokunaga, Koichi Azuma, K. Irie et al. · 1 citation
Open access Oct 2026

Sustained hepatitis D virus-ribonucleic acid negativity after self-discontinuation of short-term bulevirtide therapy: a case report

Chronic hepatitis D virus (HDV) infection represents the most severe form of viral hepatitis and is associated with accelerated progression to cirrhosis, hepatic decompensation, and hepatocellular carcinoma. Bulevirtide (BLV), an entry inhibitor targeting the NTCP receptor, has recently emerged as the standard tr...

G. Massobrio, A. Limongelli, L. Nicolini et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.